Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21421650.
- Also identified by DOI 10.1136/bjo.2010.194241 and PMC identifier 3711020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lipids and lipid metabolites have long been known to play biological roles that go beyond energy storage and membrane structure. In age-related macular degeneration and diabetes, for example, dysregulation of lipid metabolism is closely associated with disease onset and progression. At the same time, some lipids and their metabolites can exert beneficial effects in the same disorders. This review summarises our current knowledge of the contributions of lipids to both the pathogenesis and treatment of neovascular eye disease. The clinical entities covered are exudative age-related macular degeneration, diabetic retinopathy and retinopathy of prematurity, with a special emphasis on the potential therapeutic effects of ω3- (also known as n-3) polyunsaturated fatty acids.
Medical subject headings
- Eye
- Lipid Metabolism
- Neovascularization, Pathologic